Company: ZVRA
Filing Date: 2025-02-27
Form Type: 8-K
Source: 0001193125-25-037619
Chunk: 1

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-02-27
Form: 8-K
Item: Item 7.01
Chunk 1
---
Item 7.01      Regulation FD Disclosure.  

On February 27, 2025, the Company issued a press release announcing the matters disclosed in this report. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form8-Kand is incorporated herein by reference.

The information in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.

  Item 9.01      Financial Statements and Exhibits.  

  (d)      Exhibits  

  Exhibit      Description                                                                  
      No.                                                                                   
     99.1      Press Release dated February 27, 2025.                                       
 ────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)